| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Jan 25 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 21.66 | 95,500 | 2.07 mm | 95,500 |
| 3 Sep 24 | SYRE Spyre Therapeutics | Common Stock | Sell | Dispose S | No | No | 28.173 | 18,531 | 522.07 k | 116,422 |
| 1 Feb 24 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.86 | 70,000 | 1.81 mm | 70,000 |
| 22 Dec 23 | SYRE Spyre Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 134,953 | 0.00 | 134,953 |
